News about <![CDATA[GlaxoSmithKline]]> News about en-us <![CDATA[Introducing The New Global Citizen: A Leadership Chronicle]]> <![CDATA[Impax board steps in to oversee Hayward manufacturing issues]]> <![CDATA[Stepping into the Data Frontier]]> <![CDATA[Companies receiving the largest N.C. tax breaks]]> <![CDATA[Companies receiving the most NC tax breaks]]> <![CDATA[FDA approves COPD drug from Theravance, GSK]]> <![CDATA[GSK Enters New Commitment with the GAVI Alliance to Supply Cervical Cancer Vaccine for Girls in the World’s Poorest Countries]]> <![CDATA[GSK and Save the Children: An Ambitious Partnership]]> <![CDATA[GSK and Save the Children Form Unique Partnership to Save the Lives of One Million Children]]> <![CDATA[Ascletis CEO talks liver cancer, HIV]]> <![CDATA[Health Industry Plans New Business Models for 2014 - Health Minute for May 2, 2013]]> <![CDATA[Agenus trial of brain cancer vaccine shows better survival rate]]> <![CDATA[Takeaways From The 4th Annual International Corporate Volunteerism Conference: Leadership, Talent Development, and Social Impact]]> <![CDATA[GSK IMPACT Awards: Call for Applications]]> <![CDATA[Connecting GSK's Rich Tradition and Our Future in Philadelphia]]> <![CDATA[International Corporate Volunteering: Why Are IBM, Google, PepsiCo, John Deere, And Pfizer Using Volunteering To Create Their Next Generation Of Leaders?]]> <![CDATA[Measuring International Corporate Volunteerism: ICV on the Rise - CSR Minute for March 20, 2013]]> <![CDATA[GSK Publishes 2012 Corporate Responsibility Report]]> <![CDATA[$500,000 Endowment Gift from The GlaxoSmithKline Foundation Expands Program to Help Patients with Cancer and their Families at The Children’s Hospital of Philadelphia]]> <![CDATA[Getting Families Past the Hidden Costs of Cancer Treatment]]> <![CDATA[International Corporate Volunteering: Rapidly Growing Trend to Advance People, Planet, Profits]]> <![CDATA[Americans Rate Themselves and Their Communities as Healthy, Despite Research Showing the Opposite]]> <![CDATA[An Odyssey, Indeed: A Long-Lost Artwork Enters the PMA Collection.]]> <![CDATA[Building Healthy Communities]]> <![CDATA[Can Colorado be the Healthiest State?]]> <![CDATA[Healthy Denver]]> <![CDATA[Reflecting on Volunteerism]]> <![CDATA[Engaging on Patient Engagment]]> <![CDATA[GlaxoSmithKline Progresses Multi-City Discussion Focused on Improving the Health of US Communities]]> <![CDATA[Listening Leads to Innovation]]> <![CDATA[Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)]]> The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of January.

The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Dendreon (NASDAQ: DNDN), Gilead Sciences (NASDAQ: GILD), Onyx Pharmaceuticals (NASDAQ: ONXX)

]]>
<![CDATA[Reed Elsevier, HP to Launch International Health Initiatives; Pharma Drives More R&D for New Drugs to Fight Neglected Diseases - Health Minute for January 22, 2013]]> <![CDATA[Doing for Others on MLK Day of Service]]> <![CDATA[GlaxoSmithKline Promotes Community Health in St. Louis]]> <![CDATA[Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)]]> The short interest in biotech and emerging pharmaceutical companies was mixed again in the final two weeks of November. Shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN), Illumina (NASDAQ: ILMN) and Regeneron Pharmaceuticals (NASDAQ: REGN) grew somewhat between the November 15 and November

]]>
<![CDATA[Healthcare Analytics Market Projected to Gross $11B; Health Tech Startup Incubators Launch in NYC; Access to Medicines Index Says Major Drug Makers Send More Medicine to the Poor - Health Minute for D]]> <![CDATA[A Conversation on Health in St. Louis]]> <![CDATA[Three More Defensive Stock Picks for 2013 (LLY, PFE, VTR)]]> Bank of America Merrill Lynch offered some defensive stock picks for 2013 in a research report. Two drug makers and an REIT focused on health care facilities made the list. They were Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE) and Ventas (NYSE: VTR).

Here

]]>
<![CDATA[A Look at Fortune's Health Care Picks for 2013 (ALGN, FMS, GILD)]]> Three of Fortune's top 10 stock picks for 2013 are health care related companies. But they are not in big names in the sector, such as Johnson & Johnson (NYSE: JNJ) or Pfizer (NYSE: PFE). They were Align Technology (NASDAQ: ALGN), Fresenius Medical

]]>
<![CDATA[Nestle, Reckitt, and GlaxoSmithKline Place Big Bets on the Growing Market for Vitamins and Health Supplements - Health Minute For December 6, 2012]]> <![CDATA[Big Pharma Improves Access to Medicine in Developing World]]> <![CDATA[A New Study Shows the Effects of Exercising Outdoors, and GlaxoSmithKline Launches a Patient Centered Medical Program - Health Minute for December 3, 2012]]> <![CDATA[Celebrating Better Access]]> <![CDATA[The Give and Take of PULSE]]> <![CDATA[Shaping Healthcare Delivery]]> <![CDATA[New Opportunities for Patient Advocacy Leaders]]> <![CDATA[America, Complete the Cycle!]]> <![CDATA[Returning to Normal]]> <![CDATA[Jeffries Investment Bank to Host Global Healthcare Conference; GlaxoSmithKline Supports New BMJ Policy to Publish Only Articles that Reveal Patient Data - Health Minute for November 9, 2012]]> <![CDATA[GlaxoSmithKline Honors Healthcare Nonprofits with $40,000 IMPACT Awards]]>